• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What is the true rate of K-ras mutation in carcinoma of the pancreas?

作者信息

Longnecker D S, Terhune P G

出版信息

Pancreas. 1998 Nov;17(4):323-4. doi: 10.1097/00006676-199811000-00001.

DOI:10.1097/00006676-199811000-00001
PMID:9821172
Abstract
摘要

相似文献

1
What is the true rate of K-ras mutation in carcinoma of the pancreas?胰腺癌细胞中K-ras突变的真实发生率是多少？
Pancreas. 1998 Nov;17(4):323-4. doi: 10.1097/00006676-199811000-00001.
2
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.胰腺腺癌中K-ras突变与p53畸变联合存在的患病率及临床意义
Int J Pancreatol. 1997 Apr;21(2):127-43. doi: 10.1007/BF02822384.
3
The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.胰腺导管腺癌中的K-ras突变模式通常与相关的正常、增生和化生的导管上皮中的突变模式相同。
Cancer. 1999 Apr 15;85(8):1703-10.
4
Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.胰腺癌家族癌症病史与p53、p21WAF-1、HER-2/neu表达及K-ras突变的关系
Int J Pancreatol. 1997 Jun;21(3):225-34. doi: 10.1007/BF02821608.
5
Unique K-ras mutational pattern in pancreatic adenocarcinoma from Taiwanese patients.台湾患者胰腺腺癌中独特的K-ras突变模式。
Cancer Lett. 2002 Jun 28;180(2):153-8. doi: 10.1016/s0304-3835(01)00818-7.
6
K-ras mutation and pancreatic adenocarcinoma.K-ras 突变与胰腺腺癌
Int J Pancreatol. 1995 Aug;18(1):1-6. doi: 10.1007/BF02825415.
7
K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.胰腺癌患者十二指肠液中的K-ras突变
Cancer. 1998 Jan 1;82(1):96-103. doi: 10.1002/(sici)1097-0142(19980101)82:1<96::aid-cncr11>3.0.co;2-8.
8
K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head: distribution pattern and related factors.可切除性胰头腺癌肠系膜上动脉周围神经丛中的K-ras点突变：分布模式及相关因素
Arch Surg. 2000 Dec;135(12):1450-5. doi: 10.1001/archsurg.135.12.1450.
9
Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas.
Int J Cancer. 2004 Jun 10;110(2):177-82. doi: 10.1002/ijc.20084.
10
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.胰腺腺癌和胰腺导管增生患者粪便中K-ras突变的检测。
Cancer Res. 1994 Jul 1;54(13):3568-73.

引用本文的文献

1
Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases.Ras 家族信号通路在炎症性风湿病免疫发病机制中的作用。
Front Immunol. 2023 May 15;14:1151246. doi: 10.3389/fimmu.2023.1151246. eCollection 2023.
2
Mutant K-RAS Promotes Invasion and Metastasis in Pancreatic Cancer Through GTPase Signaling Pathways.突变型K-RAS通过GTP酶信号通路促进胰腺癌的侵袭和转移。
Cancer Growth Metastasis. 2015 Oct 19;8(Suppl 1):95-113. doi: 10.4137/CGM.S29407. eCollection 2015.
3
Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
胰十二指肠切除术切除的胰腺癌、壶腹癌、胆管癌和十二指肠癌的分布及病理特征
World J Surg Oncol. 2015 Feb 28;13:85. doi: 10.1186/s12957-015-0498-5.
4
BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas.胰腺导管内乳头状黏液性肿瘤/癌（IPMN/IPMC）中的BRAF和KRAS基因突变
Cancer Lett. 2007 May 8;249(2):242-8. doi: 10.1016/j.canlet.2006.09.007. Epub 2006 Nov 9.
5
Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.与胰腺导管腺癌和慢性胰腺炎相关的胰腺导管内瘤变中K-ras突变的频率：一项荟萃分析。
Neoplasia. 2005 Jan;7(1):17-23. doi: 10.1593/neo.04445.
6
A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.一种在人胰腺癌细胞中选择性诱导程序性细胞死亡的组合方法。
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10332-7. doi: 10.1073/pnas.171315198.
7
K-Ras mutations and benign pancreatic disease.K-Ras基因突变与胰腺良性疾病
Int J Pancreatol. 2000 Apr;27(2):93-103. doi: 10.1385/IJGC:27:2:093.
8
Current approaches and future strategies for pancreatic carcinoma.
Invest New Drugs. 2000 Feb;18(1):43-56. doi: 10.1023/a:1006383831045.
9
Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.胰腺黏液性囊性肿瘤进展为恶性肿瘤过程中K-ras突变和p53过表达的序贯性积累。
Ann Surg. 1999 Oct;230(4):501-9; discussion 509-11. doi: 10.1097/00000658-199910000-00006.